Home / Investor & Media / Events & Presentations / Tivantinib METIV-HCC Trial and Proprietary Pipeline Update Conference Call
These archived presentations and related materials are provided for reference by ArQule, Inc. Information contained in the materials was current only as of the date of the event. ArQule, Inc. does not update or delete outdated information contained in these materials, and it expressly disclaims any obligation to do so. The materials are property of ArQule, Inc. and any use, dissemination or republication of the files is prohibited without the express written consent of ArQule, Inc.
I Accept, continue to event
I Decline, take me back to the previous page
Please feel free to contact by one of the methods below
Online Form Call (781) 994-0300